BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Technetium-99m labeled radiopharmaceutical kit for imaging
Abstract:The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m and which can be targeted to specific sites within a mammalian body.
Inventor(s): Dean; Richard T. (Bedford, NH)
Assignee: Diatide, Inc. (Londonderry, NH)
Filing Date:Jun 05, 1995
Application Number:08/464,456
Claims:1. A kit for preparing a radiopharmaceutical that is a scintigraphic imaging agent for imaging target sites within a mammalian body, said kit comprising a sealed vial containing a predetermined quantity of a reagent for preparing the scintigraphic imaging agent, wherein the reagent comprises, in combination:

(a) a specific binding peptide comprising 3 to 100 amino acids that specifically binds to the target site to be imaged and

(b) a technetium-99 m binding moiety of the formula

wherein Cp is a cysteine amino acid residue and (aa) is any amino acid and wherein the technetium-99 m binding moiety is covalently bound to the specific binding peptide to comprise the reagent, and a sufficient amount of reducing agent to label said reagent with technetium-99 m.

2. A kit according to claim 1 wherein the reagent comprises a specific binding peptide and a Cp(aa)Cp moiety that are covalently linked through from about one to about ninety amino acids.

3. A kit according to claim 1 wherein the reagent comprises a technetium-99 m binding moiety wherein the sidechain sulfur atom of the cysteine residue of the technetium-99 m binding moiety is protested by a protecting group of the formula

wherein R is a lower alkyl having 1 to 6 carbon atoms, phenyl, or phenyl substituted with lower alkyl, hydroxy, lower alkoxy, carboxy, or lower alkoxycarbonyl, or 2-,3-,4- pyridyl.

4. A kit according to claim 1 wherein the reagent comprises a technetium-99 m binding moiety having the formula: ##STR8##

5. A kit according to claim 1 wherein the reagent comprises a specific binding peptide selected from the group consisting of peptides having the formula:
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: